Recently, news broke about Wirano - international digital platform for clinical trials launched by PF Rus, LLC. Mainly it is aimed at making convenient collaboration and communication of all the parties involved in the business, e.g., pharmaceutical companies, scientists, doctors and patients.
Russian pharmaceutical market demonstrates rapid development resulting in drugs manufacture localization; this is explained by the course of the Russian government to substitute and decrease the proportion of the imported drugs. Also, the dynamics of the Russian pharmaceutical market development is progressive. This leads to constant increasing value and importance of reference and generic drugs.
First half of 2020 revealed significant amount of 87,3 billion of active pharmaceutical ingredients imported to Russia. Compared to last year, 54% increase is evidenced.
2020 is marked with coronavirus infection, which affected all the aspects of human activity, including cargo transportation, delivery of raw materials and food. The situation is so serious that in early April, associates of the International Road Transport Union (IRU) and the I International Transport Workers Federation addressed an open letter to their governments. They asked for a support in a closed borders reality.
Next year will be a challenge for a pharmaceutical Russian market as a result of unified tax on imputed income cancellation, labelling and 20% market limitation for drug stores.
